Is this you?
Request access for Tallahassee Research Institute using your company work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Tallahassee Research Institute
Unclaimed profileIndependent Site · Florida · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall65Recruit42Ops79Sponsor69Ther74
Performance (observed)
Historical trials
200
Completed
130
Terminated/Withdrawn
17
Completion rate
88%
Active now
49
Phase 2
32
Phase 3
69
Realized enrollment
236,526
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
7,391
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
273
States
Florida
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Radiation Therapy Oncology Group; Boston Scientific Corporation; Abbott Medical Devices; Eli Lilly and Company; Susanna Naggie, MD; Shockwave Medical, Inc.
CROs
Novotech Health Holdings Pte. Ltd.
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
hopefullybrianna@gmail.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall65
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.